SEC Form 4 · accession 0001093557-16-000462
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorge A Valdes
Officer — CTO
Period of report
Mar 10, 2016
Accepted (ET)
Mar 14, 2016 · 8:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 11, 2016 | J | 11,937 | $65.15 | D | 91,667 | D | |
| Common StockF3,F4 | Mar 10, 2016 | D | 4,725 | $63.18 | D | 22,129 | I | by Trust |
| Common StockF3,F4 | Mar 10, 2016 | D | 8,133 | $63.18 | D | 13,996 | I | by Trust |
| Common StockF1,F4 | Mar 11, 2016 | J | 11,937 | $65.15 | A | 25,933 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units.
- F2Included in this number are 91,667 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest on March 8, 2019, 30,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 23,667 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
- F3These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- F4Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.